Development and criterion validity of the COVID-19 anxiety and fear assessment scale: a cross sectional study.
COVID-19
Fear
anxiety
instrument development
mental health
public health
Journal
Science progress
ISSN: 2047-7163
Titre abrégé: Sci Prog
Pays: England
ID NLM: 0411361
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
entrez:
26
10
2021
pubmed:
27
10
2021
medline:
3
11
2021
Statut:
ppublish
Résumé
The emergence of the new severe acute respiratory syndrome coronavirus 2, which causes COVID-19 disease, has been a major public health challenge and an increase in the feeling of uncertainty of the population, who is also experiencing an increase in levels of anxiety and fear regarding the COVID-19 disease. The objective of the study was the construct and criterion validation of the Descriptive study of psychometric validation. A field study was carried out to execute univariate and bivariate analyses, in addition to the exploratory and confirmatory factorial analysis of the scale. For the criteria validity study, the The study sample was composed of 1036 subjects over 18 years of age, who resided in Spain, where 56.3% were women with a mean age of 48.11 years (SD = 15.13). The study of construct validity reported two factors and 16 items, with a Cronbach's alpha value of 0.92. The scale was concurrently valid with the used gold standard and obtained sensitivity values of 90.48% and specificity values of 76%. The AMICO scale is valid and reliable for assessing the level of anxiety and fear of COVID-19 in the adult Spanish population and is highly sensitive.
Sections du résumé
BACKGROUND
The emergence of the new severe acute respiratory syndrome coronavirus 2, which causes COVID-19 disease, has been a major public health challenge and an increase in the feeling of uncertainty of the population, who is also experiencing an increase in levels of anxiety and fear regarding the COVID-19 disease.
OBJECTIVE
The objective of the study was the construct and criterion validation of the
METHODS
Descriptive study of psychometric validation. A field study was carried out to execute univariate and bivariate analyses, in addition to the exploratory and confirmatory factorial analysis of the scale. For the criteria validity study, the
RESULTS
The study sample was composed of 1036 subjects over 18 years of age, who resided in Spain, where 56.3% were women with a mean age of 48.11 years (SD = 15.13). The study of construct validity reported two factors and 16 items, with a Cronbach's alpha value of 0.92. The scale was concurrently valid with the used gold standard and obtained sensitivity values of 90.48% and specificity values of 76%.
CONCLUSIONS
The AMICO scale is valid and reliable for assessing the level of anxiety and fear of COVID-19 in the adult Spanish population and is highly sensitive.
Identifiants
pubmed: 34698544
doi: 10.1177/00368504211050291
pmc: PMC10306143
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
368504211050291Références
Milbank Q. 2005;83(4):691-729
pubmed: 16279964
Int J Environ Res Public Health. 2020 Jun 02;17(11):
pubmed: 32498401
Actas Esp Psiquiatr. 2016 May;44(3):83-92
pubmed: 27254400
Psychiatry Res. 2020 Nov;293:113350
pubmed: 32777619
Brain Sci. 2021 Mar 05;11(3):
pubmed: 33807643
Clin Psychol Rev. 2011 Feb;31(1):122-37
pubmed: 20817337
Lancet. 2020 Feb 22;395(10224):e37-e38
pubmed: 32043982
J Affect Disord. 2020 Dec 1;277:379-391
pubmed: 32861839
Rev Esp Geriatr Gerontol. 2019 Jan - Feb;54(1):34-48
pubmed: 30340781
Infect Dis Poverty. 2020 Mar 17;9(1):29
pubmed: 32183901
Int J Ment Health Addict. 2022;20(1):273-283
pubmed: 32837435
Int J Ment Health Addict. 2021;19(6):2219-2232
pubmed: 32427217
BMC Public Health. 2021 Jan 11;21(1):118
pubmed: 33430852
Int J Ment Health Addict. 2022;20(2):888-894
pubmed: 33192199
Int J Ment Health Addict. 2022;20(3):1537-1545
pubmed: 32226353
Healthcare (Basel). 2020 Jun 28;8(3):
pubmed: 32605264
Int J Ment Health Addict. 2022;20(4):1913-1922
pubmed: 32372892
J Clin Epidemiol. 2015 Apr;68(4):435-41
pubmed: 25698408
Gen Psychiatr. 2020 Mar 6;33(2):e100213
pubmed: 32215365
PeerJ. 2021 Apr 26;9:e11263
pubmed: 33981502
Front Psychol. 2020 Sep 29;11:565823
pubmed: 33132969
Rev Esp Geriatr Gerontol. 2017 Jul - Aug;52(4):197-200
pubmed: 28559095
Ir J Psychol Med. 2021 Dec;38(4):266-271
pubmed: 33526156
Int J Ment Health Addict. 2021;19(6):1980-1988
pubmed: 32395095
J Nurs Manag. 2021 Jul;29(5):1016-1025
pubmed: 33400325
Saf Sci. 2021 Jan;133:104996
pubmed: 32952305
Front Psychol. 2020 Jun 23;11:1540
pubmed: 32655463
BMJ. 2020 Jan 28;368:m313
pubmed: 31992552
BMC Med Res Methodol. 2021 Apr 23;21(1):82
pubmed: 33892631
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):203-208
pubmed: 32391665
Nurs Open. 2021 Jul;8(4):1892-1908
pubmed: 33745219